ConductScience.org, home

Paper42412349

Allogeneic hematopoietic cell transplantation with reduced-toxicity conditioning for X-linked hyper-IgM syndrome.

Wakatsuki R and 16 others. Int J Hematol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Allogeneic hematopoietic cell transplantation with reduced-toxicity conditioning for X-linked hyper-IgM syndrome. Papers, record 42412349. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42412349

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Allogeneic hematopoietic cell transplantation with reduced-toxicity conditioning for X-linked hyper-IgM syndrome.
PubMed
Journal
Int J Hematol
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-11-01
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wakatsuki RRyosuke
2Miyamoto SSatoshi
3Hoshino AAkihiro
4Takahashi SShuhei
5Ishibashi YYusuke
6Watanabe RRyohei
7Magara TTatsuya
8Tomomasa DDan
9Nishimura AAkira
10Suzuki KKyogo
11Kamiya TTakahiro
12Isoda TTakeshi
13Imai KKohsuke
14Kajiwara MMichiko
15Morio TTomohiro
16Takagi MMasatoshi
17Kanegane HHirokazuhttps://orcid.org/0000-0002-8696-9378

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Transplantation ConditioningMajor topic
Hematopoietic Stem Cell TransplantationMajor topic
Hyper-IgM Immunodeficiency Syndrome, Type 1Major topic
Humans
Child, Preschool
Male
Female
Transplantation, Homologous
Vidarabine
Graft vs Host Disease
Busulfan
Whole-Body Irradiation
Survival Rate

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
22K07887Japan Society for the Promotion of SciencePubMed

Source PubMed

Download CSV of grants

References23

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123797640The hyper IgM syndromes.Clin Rev Allergy Immunol2014https://conductscience.org/library/papers/23797640PubMed
227697500Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation.J Allergy Clin Immunol2017https://conductscience.org/library/papers/27697500PubMed
338568018Lesson learned in pediatric haploidentical transplantation in a low-resource environment: delivering melphalan IV and using low dose radiation reduce graft failure.Hematology2024https://conductscience.org/library/papers/38568018PubMed
429132233Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome.Innate Immun2018https://conductscience.org/library/papers/29132233PubMed
57681587Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/7681587PubMed
67679801CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome.Science1993https://conductscience.org/library/papers/7679801PubMed
732849512Macrophages Orchestrate Hematopoietic Programs and Regulate HSC Function During Inflammatory Stress.Front Immunol2020https://conductscience.org/library/papers/32849512PubMed
816630945Defects of class-switch recombination.J Allergy Clin Immunol2006https://conductscience.org/library/papers/16630945PubMed
933527309Hematopoietic Cell Transplantation with Reduced Intensity Conditioning Using Fludarabine/Busulfan or Fludarabine/Melphalan for Primary Immunodeficiency Diseases.J Clin Immunol2021https://conductscience.org/library/papers/33527309PubMed
108094231CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM.Nature1993https://conductscience.org/library/papers/8094231PubMed
1141608114Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee.J Hum Immun2025https://conductscience.org/library/papers/41608114PubMed
1236797422Graft-versus-host disease-free, relapse-free, second transplant-free survival in allogeneic hematopoietic cell transplantation for genetic disorders.Bone Marrow Transplant2023https://conductscience.org/library/papers/36797422PubMed
137679206Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM.Nature1993https://conductscience.org/library/papers/7679206PubMed
147678782The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome.Cell1993https://conductscience.org/library/papers/7678782PubMed
1514663287The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients.Medicine (Baltimore)2003https://conductscience.org/library/papers/14663287PubMed
1622038983Hemophagocytic lymphohistiocytosis after hematopoietic stem cell transplantation in children: a nationwide survey in Japan.Pediatr Blood Cancer2012https://conductscience.org/library/papers/22038983PubMed
1734226669EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity.Bone Marrow Transplant2021https://conductscience.org/library/papers/34226669PubMed
1835759077B-Cell Immune Reconstitution with Mixed Chimerism After Hematopoietic Cell Transplantation in a Patient with Severe Combined Immunodeficiency.J Clin Immunol2022https://conductscience.org/library/papers/35759077PubMed
1942002229Posttransplant Chimerism Estimation Using Variant-Specific ddPCR in Inborn Errors of Immunity.Transplant Cell Ther2026https://conductscience.org/library/papers/42002229PubMed
2030660643Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC study.J Allergy Clin Immunol2019https://conductscience.org/library/papers/30660643PubMed

See all 23 referencesDownload CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD40LG959PubTator's text mininghttps://conductscience.org/library/genes/959

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42412349

GET https://conductscience.org/api/papers/v1/42412349/references?page=2